EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Primary non-hepatoblastoma liver tumors in children—Defining the profile of a very rare subset of childhood tumors

Abha Mehta, Badira Cheriyalinkal Parambil, Akshay Baheti, Venkata Ram Mohan Gollamudi, Maya Prasad, Vasundhara Patil, Sajid Qureshi, Mukta Ramadwar, Poonam Panjwani, Kunal Gala, Siddhartha Laskar, Nehal Khanna und 3 weitere

Indian Journal of Gastroenterology · 2025

DOI: 10.1007/s12664-025-01823-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Gastroenterology, 2025. Verfasst von Abha Mehta und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, 400 012, India. Hauptthemen laut MEDLINE: Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tata Memorial Hospital - TMC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Primary pediatric non-hepatoblastoma (n-HB) liver tumors are rare with limited literature on their clinical-epidemiological profile and outcomes. We audit the above in this study.

Methods

Children diagnosed with n-HB primary liver tumors from January 2012 to December 2023 were analyzed retrospectively. Patients underwent contrast-enhanced computed tomography (CECT) of the abdomen and computed tomography (CT) of the thorax or fluorodeoxyglucosepositron emission tomography/computed tomography (FDG-PET/CT) for staging of malignant tumors. Treatment was administered based on the definitive diagnosis.

Results

Sixty-nine patients formed the study cohort. The most common tumors in various age groups were infantile hepatic hemangioma (IHH)—66.7%, malignant rhabdoid tumor (MRT)—25%; six months to three years: MRT—25.0%, mesenchymal hamartoma and hemangioendothelioma—18.7% each; three to 10 years: hepatocellular carcinoma (HCC)—31.6%, undifferentiated embryonal sarcoma of the liver (UESL)—26.3%; and > = 10 years: HCC—45.4%, UESL—22.7%. Median alpha-fetoprotein (AFP) level in HCC was 131,249 ng/mL. Treatment was delivered to 65.8% patients. Chemotherapy for treated malignant tumors was administered in 81.5%, surgery in 85.2% and radiotherapy in 18.5%, alone or combined. In the different malignant cancer sub-types, the proportion of relapse/deaths in treated patients was HCC—22.2%, UESL—33.3%, rhabdoid—25%, hemangioendotheliomas—25% and sarcomas—25%.

Conclusions

There was a high proportion of malignant rhabdoid tumors and higher serum AFP levels in HCC in our cohort. The overall outcomes of treated malignant tumors were relatively favorable, though limited by the sample size in this rare cohort. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsHumansFemaleRetrospective StudiesInfantMaleChild, PreschoolChildCarcinoma, HepatocellularRhabdoid TumorTomography, X-Ray Computedalpha-FetoproteinsHemangiomaHemangioendotheliomaNeoplasm StagingPositron Emission Tomography Computed Tomography

Stichwörter der Autor:innen

ChildrenLiver tumorsNon-hepatoblastomaPrimary hepatic malignancies

Substanzen

alpha-Fetoproteins

Autor:innen und Institutionen

  • Division of Pediatric Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, 400 012, India.
  • Division of Pediatric Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, 400 012, India. badiracp@yahoo.co.in.
  • Department of Radiodiagnosis, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, 400 012, India.
  • Department of Pediatric Surgery, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, 400 012, India.
  • Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, 400 012, India.
  • Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, 400 012, India.

Förderung

  • Tata Memorial Hospital - TMC

Zitieren

APA

Mehta, A., Parambil, B. C., Baheti, A., Gollamudi, V. R. M., Prasad, M., Patil, V., Qureshi, S., Ramadwar, M., Panjwani, P., Gala, K., Laskar, S., Khanna, N., Manjali, J. J., Shah, S., & Chinnaswammy, G. (2025). Primary non-hepatoblastoma liver tumors in children—Defining the profile of a very rare subset of childhood tumors. Indian Journal of Gastroenterology. https://doi.org/10.1007/s12664-025-01823-2

Vancouver

Mehta A, Parambil BC, Baheti A, Gollamudi VRM, Prasad M, Patil V, et al. Primary non-hepatoblastoma liver tumors in children—Defining the profile of a very rare subset of childhood tumors. Indian Journal of Gastroenterology. 2025. doi:10.1007/s12664-025-01823-2

BibTeX
@article{Mehta2025,
  author = {Mehta, Abha and Parambil, Badira Cheriyalinkal and Baheti, Akshay and Gollamudi, Venkata Ram Mohan and Prasad, Maya and Patil, Vasundhara and Qureshi, Sajid and Ramadwar, Mukta and Panjwani, Poonam and Gala, Kunal and Laskar, Siddhartha and Khanna, Nehal and Manjali, Jifmi Jose and Shah, Sneha and Chinnaswammy, Girish},
  title = {Primary non-hepatoblastoma liver tumors in children—Defining the profile of a very rare subset of childhood tumors},
  journal = {Indian Journal of Gastroenterology},
  year = {2025},
  doi = {10.1007/s12664-025-01823-2}
}
Kostenlos starten →